uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted February 28, 2017

Seller of Tea Supplements Warned for Manufacturing Violations

On February 3, 2017, the FDA issued a warning letter to Kumato Labs, following a facility inspection which found the company's products, including CHO WA Tea, COMOXIN IBS Formula and NEMURI Sleep Formula to be adulterated because they were prepared, packed, or held under conditions that violate Current Good Manufacturing Practices for dietary supplements.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at